...
首页> 外文期刊>Epilepsia: Journal of the International League against Epilepsy >Mutational analysis of nicotinic acetylcholine receptor beta2 subunit gene (CHRNB2) in a representative cohort of Italian probands affected by autosomal dominant nocturnal frontal lobe epilepsy.
【24h】

Mutational analysis of nicotinic acetylcholine receptor beta2 subunit gene (CHRNB2) in a representative cohort of Italian probands affected by autosomal dominant nocturnal frontal lobe epilepsy.

机译:烟碱乙酰胆碱受体β2亚基基因(CHRNB2)的突变分析在常染色体显性夜夜额叶癫痫发作的意大利先证者的典型队列中。

获取原文
获取原文并翻译 | 示例
           

摘要

Twenty-four autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) probands were analyzed for the presence of V287L and V287M mutations in the CHRNB2 gene, which have been recently associated with the disease. In all patients, the involvement of the two additional loci reported as being associated with ADNFLE (CHRNA4 gene and chromosome 15q24 region) had been previously excluded. Mutational screening was performed by sequencing a polymerase chain reaction-amplified CHRNB2 DNA fragment, spanning the whole exon 5, which contains the V287L and V287M mutations and codes for approximately 65% of the mature protein. In none of the patients were mutations in the analyzed region of CHRNB2 found. These data, obtained in the largest ADNFLE cohort so far analyzed, demonstrate the rarity of the identified CHRNB2 mutations in ADNFLE patients.
机译:分析了24个常染色体显性夜夜性额叶癫痫(ADNFLE)先证者在CHRNB2基因中是否存在V287L和V287M突变,这些突变最近与该疾病有关。在所有患者中,先前已排除了另外两个与ADNFLE相关的基因座(CHRNA4基因和15q24染色体区域)的参与。通过对聚合酶链反应扩增的CHRNB2 DNA片段进行测序来进行突变筛选,该片段跨越整个外显子5,该外显子5包含V287L和V287M突变,编码大约65%的成熟蛋白。在所有患者中均未发现CHRNB2分析区域的突变。这些数据是迄今为止最大的ADNFLE队列研究中获得的,证明了ADNFLE患者中已鉴定出的CHRNB2突变的罕见性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号